1 / 7

Oxycodone Market Growth Drivers, Industry Challenges and Opportunities to 2027

An extensive study of the product application and services conducted by subject matter experts assessing the market will help product owners to make a wise decision.

samvi
Download Presentation

Oxycodone Market Growth Drivers, Industry Challenges and Opportunities to 2027

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Oxycodone Market To Reach USD 6.78 Billion By 2026 | Johnson & Johnson, Sanofi, Pfizer, Purdue Pharma

  2. Market Summary The oxycodone market is driven by an increase in the number of patients suffering from terminally ill diseases. Market Size – USD 4.68 Billion in 2018, Market Growth - CAGR of 4.6%, Market Trends – Expanding occurrence of diseases that cause chronic pain, such as postsurgical pain, back pain, cancer and fibromyalgia is boosting the market.

  3. Our Approach Our Approach Market Summary The Oxycodone Market is estimated to grow from USD 4.68 Billion in 2018 to USD 6.78 Billion by 2026, at a CAGR of 4.6%, during the forecast period. The oxycodone market is driven by an increase in the number of patients suffering from terminally ill diseases such as cancer and HIV and a high increase in the prescription of post-operative pain medication. Cancer's growing commonness, Parkinson's disease, and rheumatic diseases drive the growth of the market. The use of oxycodone to relieve post-operative pain under different medical conditions fuels the growth of the market. Increasing concern about oxycodone abuse, however, is curbing market growth. However, less addictive oxycodone drugs approved by the FDA for adults and children are likely to open new gateways in the forecast period for the growth of Oxycodone Market. Request for a sample of this research report @ https://www.reportsanddata.com/sample-enquiry-form/1286

  4. Our Approach Our Approach Market Summary Further key findings from the report suggest • The Oxycodone Market is estimated to grow from USD 4.68 Billion in 2018 to USD 6.78 Billion by 2026, at a CAGR of 4.6%, during the forecast period. The oxycodone market is driven by an increase in the number of patients suffering from terminally ill diseases such as cancer and HIV and a high increase in the prescription of post-operative pain medication. • The market for short acting oxycodone is expected to hold the largest market share at USD 5.09 Billion by 2026, at a CAGR of 5.5% during the forecast period. An increase in pharmaceutical companies new drug applications and the number of products in the pipeline are driving the market for oxycodone. Other formulations are coming up on the market, such as controlling the release of drugs to improve pain management. • Based on routes of administration, the oral segment is expected to hold the largest market share and is expected to reach USD 2.98 Billion by 2026, at a CAGR of 5.8% during the forecast period. Oxycodone is only approved for mouth use in the United States, which is available as tablets and oral solutions. However, oxycodone parenteral formulations (brand name OxyNorm) are also available worldwide and are widely used in Europe. To identify the key trends in the industry, click on the link below@ https://www.reportsanddata.com/report-detail/oxycodone-market

  5. Our Approach Our Approach Market Summary Key participants : Johnson & Johnson (US), Sanofi (France), Pfizer (US), Purdue Pharma (US), Endo International (Ireland), Teva Pharmaceuticals (Israel), Hikma Pharmaceuticals (UK), Mallinckrodt (UK), Mylan (US), Sun Pharmaceutical (India), Impax Laboratories (US), Indivior (UK) and others.. Type (Kilo Tons) (Revenue, USD Million; 2016-2026) Short Acting Oxycodone Long Acting Oxycodone Routes of Administration (Kilo Tons) (Revenue, USD Million; 2016-2026) Oral Sublingual Intramuscular Intravenous Intranasal Subcutaneous

  6. Our Approach Our Approach Market Summary Distribution (Kilo Tons) (Revenue, USD Million; 2016-2026) Hospital Pharmacies Retail Pharmacies Others Application (Kilo Tons) (Revenue, USD Million; 2016-2026) De-Addiction Pain Management Order Now @ https://www.reportsanddata.com/checkout-form/1286

  7. About Us Our Approach Our Approach About Us About Us Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Contact Us: John Watson Head of Business Development Reports And Data | Web: www.reportsanddata.com Direct Line: +1-212-710-1370 E-mail: sales@reportsanddata.com

More Related